Matthew T E McLaughlin
2019
In 2019, Matthew T E McLaughlin earned a total compensation of $1.3M as Chief Financial Officer at Oxford Immunotec Global.
Compensation breakdown
| Non-Equity Incentive Plan | $195,781 |
|---|---|
| Option Awards | $425,000 |
| Salary | $242,000 |
| Stock Awards | $425,000 |
| Other | $373 |
| Total | $1,288,154 |
McLaughlin received $425K in option awards, accounting for 33% of the total pay in 2019.
McLaughlin also received $195.8K in non-equity incentive plan, $242K in salary, $425K in stock awards and $373 in other compensation.
Rankings
In 2019, Matthew T E McLaughlin's compensation ranked 8,073rd out of 13,971 executives tracked by ExecPay. In other words, McLaughlin earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,073 out of 13,971 | 42nd |
Division Manufacturing | 3,190 out of 5,701 | 44th |
Major group Chemicals And Allied Products | 1,212 out of 2,200 | 45th |
Industry group Drugs | 1,032 out of 1,886 | 45th |
Industry In Vitro and In Vivo Diagnostic Substances | 28 out of 77 | 64th |
Source: SEC filing on April 29, 2020.
McLaughlin's colleagues
We found two more compensation records of executives who worked with Matthew T E McLaughlin at Oxford Immunotec Global in 2019.